Lv3
240 积分 2020-05-14 加入
Process optimization using machine learning enhanced design of experiments (DOE): ranibizumab refolding as a case study
1个月前
已完结
Implementation of Design of Experiment (DoE) for process development and optimization of biosimilars
1个月前
已完结
The effect of kosmotropic salts on aggregate removal from monoclonal antibodies in mixed-mode anion exchange chromatography
1个月前
已完结
Removing a light-chain missing byproduct by MMC ImpRes mixed-mode chromatography under weak partitioning mode in purifying a WuXiBody-based bispecific antibody
1个月前
已完结
Pharmaceutical aspects of mAbs: formulation, characterization, and current route of administration of monoclonal antibody therapies
2个月前
已完结
Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics
2个月前
已完结
Application of Quality by Design to the characterization of the cell culture process of an Fc-Fusion protein
2个月前
已完结
Application of a Quality by Design Approach to the Cell Culture Process of Monoclonal Antibody Production, Resulting in the Establishment of a Design Space
2个月前
已完结
Considerations for operational space definition and optimization of a no‐salt flowthrough hydrophobic interaction chromatography purification step
2个月前
已完结
Resin and loading condition screening for effective and robust byproducts removal by anion exchange chromatography: A case study
2个月前
已完结
皖公网安备34019202002308
